-+ 0.00%
-+ 0.00%
-+ 0.00%

PURETECH ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING WITH FDA FOR DEUPIRFENIDONE (LYT-100) IN IDIOPATHIC PULMONARY FIBROSIS

Reuters·12/08/2025 07:00:02

Please log in to view news